AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2023
Jan 5, 2023
33298_dirs_2023-01-05_ede2871c-c77f-4ea9-82de-13dbc575196b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2023-01-03
Reporting Person: FRIEDEMAN JESSICA (Chief Marketing Officer)
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17